Sandeep Grover

Sandeep Grover, MD

Professor; Associate Chair, Department of Ophthalmology; Medical Director, Ophthalmology Trauma Service

Department: Ophthalmology – Jacksonville
Business Phone: (904) 244-9390
Business Email: sandeep.grover@jax.ufl.edu

About Sandeep Grover

Dr. Sandeep Grover is a University of Florida professor of ophthalmology at UF Health Jacksonville. He is a medical retina specialist and is a leading authority on inherited retinal diseases. He has vast experience in managing retinal diseases, such as diabetic retinopathy and macular degeneration.

Additional Positions:
Professor
2020 – Current · University of Florida
Medical Director, Ophthalmology Trauma Service
2016 – Current · University of Florida
Associate Chair, Department of Ophthalmology
2016 – Current · University of Florida
Associate Program Director, Ophthalmology Residency
2008 – 2016 · University of Florida
Assistant Professor
2005 – 2020 · University of Florida

Accomplishments

10-Year Service Pin
2015 · University of Florida College of Medicine – Jacksonville

Teaching Profile

Courses Taught
2014-2018
MDT7550 Elect Top/Opthalmol

Clinical Profile

Dr. Grover’s clinical areas of interest are macular degeneration, diabetic retinopathy, retinal vascular occlusions and inherited retinal diseases like retinitis pigmentosa, cone-rod dystrophy, Stargardt disease, etc.

Specialties
  • Ophthalmology
Subspecialties
  • Retina
Areas of Interest
  • Adult cataract
  • Age-related macular degeneration
  • Cataract removal
  • Diabetes and eye disease
  • Retina
  • Retinal detachment
  • Retinal detachment repair
  • Retinitis pigmentosa
  • Uveitis

Publications

Academic Articles
2022
ASSESSMENT OF FLUORESCEIN ANGIOGRAPHY NONPERFUSION IN EYES WITH DIABETIC RETINOPATHY USING ULTRAWIDE FIELD RETINAL IMAGING.
Retina (Philadelphia, Pa.). 42(7):1302-1310 [DOI] 10.1097/IAE.0000000000003479. [PMID] 35344528.
2021
Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography Instruments.
Translational vision science & technology. 10(14) [DOI] 10.1167/tvst.10.14.34. [PMID] 34967834.
2021
Evidence-Based Protocol for Ophthalmology Consult for Orbital Fractures.
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 79(7):1507-1513 [DOI] 10.1016/j.joms.2021.02.026. [PMID] 33757741.
2019
Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy.
JAMA ophthalmology. 137(1):65-73 [DOI] 10.1001/jamaophthalmol.2018.4982. [PMID] 30347105.
2019
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
JAMA. 321(19):1880-1894 [DOI] 10.1001/jama.2019.5790. [PMID] 31037289.
2019
EXTREME DIURNAL VARIATION OF CENTRAL MACULAR THICKNESS IN DIABETIC MACULAR EDEMA.
Retinal cases & brief reports. 13(4):324-326 [DOI] 10.1097/ICB.0000000000000587. [PMID] 28333856.
2019
TEMPORAL THINNING IN SICKLE CELL RETINOPATHY IS ASSOCIATED WITH DIMINISHED PERFUSION ON OCTA AND DENSE SCOTOMA ON MICROPERIMETERY.
Retinal cases & brief reports. 13(4):308-313 [DOI] 10.1097/ICB.0000000000000610. [PMID] 28644178.
2018
CHANGES IN DIABETIC RETINOPATHY SEVERITY WHEN TREATING DIABETIC MACULAR EDEMA WITH RANIBIZUMAB: DRCR.net Protocol I 5-Year Report.
Retina (Philadelphia, Pa.). 38(10):1896-1904 [DOI] 10.1097/IAE.0000000000002302. [PMID] 30234859.
2018
SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY VALIDATES LAMINA CRIBROSA ANOMALY IN OPTIC DISK PIT.
Retinal cases & brief reports. 12(1):42-44 [DOI] 10.1097/ICB.0000000000000410. [PMID] 27662409.
2017
Inhibition of proliferation of retinal vascular endothelial cells more effectively than choroidal vascular endothelial cell proliferation by bevacizumab.
International journal of ophthalmology. 10(1):15-22 [DOI] 10.18240/ijo.2017.01.03. [PMID] 28149771.
2017
The application of optical coherence tomography angiography in retinal diseases.
Survey of ophthalmology. 62(6):838-866 [DOI] 10.1016/j.survophthal.2017.05.006. [PMID] 28579550.
2016
Capillary nonperfusion by novel technology of OCT angiography in a patient with sickle cell disease with normal fluorescein angiogram.
European journal of ophthalmology. 26(5):e121-3 [DOI] 10.5301/ejo.5000765. [PMID] 26951533.
2016
Clinical applications of spectral domain optical coherence tomography in retinal diseases.
Biomedical journal. 39(2):107-20 [DOI] 10.1016/j.bj.2016.04.003. [PMID] 27372166.
2016
EVALUATION OF PORTABLE DIGITAL FUNDUS VIDEO CAMERA FOR FLUORESCEIN ANGIOGRAPHY.
Retina (Philadelphia, Pa.). 36(3):651-5 [DOI] 10.1097/IAE.0000000000000920. [PMID] 26716958.
2016
Intraocular Pressure in Premature Low Birth Weight Infants.
Journal of pediatric ophthalmology and strabismus. 53(5):300-4 [DOI] 10.3928/01913913-20160629-03. [PMID] 27637021.
2016
Replay to: Normative data for macular volume with high-definition spectral-domain optical coherence tomography (Spectralis).
European journal of ophthalmology. 26(2) [DOI] 10.5301/ejo.5000714. [PMID] 26659021.
2015
Bilateral Choroidal Detachment in Waldenström Macroglobulinemia.
JAMA ophthalmology. 133(6):715-6 [DOI] 10.1001/jamaophthalmol.2015.64. [PMID] 26067691.
2015
Comparison of central corneal thickness: ultrasound pachymetry versus slit-lamp optical coherence tomography, specular microscopy, and Orbscan.
Clinical ophthalmology (Auckland, N.Z.). 9:1065-70 [DOI] 10.2147/OPTH.S81376. [PMID] 26109840.
2015
Effect of distance and duration of illumination on retinal ganglion cells exposed to varying concentrations of brilliant blue green.
Journal of clinical medicine research. 7(7):517-24 [DOI] 10.14740/jocmr2085e. [PMID] 26015816.
2015
Evaluation of the iPad as a low vision aid for improving reading ability.
Clinical ophthalmology (Auckland, N.Z.). 9:17-20 [DOI] 10.2147/OPTH.S73193. [PMID] 25552897.
2015
Normative data for macular volume with high-definition spectral-domain optical coherence tomography (Spectralis).
European journal of ophthalmology. 25(6):546-51 [DOI] 10.5301/ejo.5000582. [PMID] 25952713.
2014
Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration.
Journal of ophthalmology. 2014 [DOI] 10.1155/2014/502174. [PMID] 25110587.
2014
Retinal thickness measurement obtained with spectral domain optical coherence tomography assisted optical biopsy accurately correlates with ex vivo histology.
PloS one. 9(10) [DOI] 10.1371/journal.pone.0111203. [PMID] 25360629.
2013
Acute, bilateral, concurrent central retinal artery occlusion in sickle cell disease after use of tadalafil (Cialis).
JAMA ophthalmology. 131(11):1471-3 [DOI] 10.1001/jamaophthalmol.2013.5047. [PMID] 24052082.
2013
Differential sensitivity of choroidal endothelial, retinal ganglion, and retinal pigment epithelial cells in vitro to proton radiation.
American journal of ophthalmology. 156(3):444-453.e2 [DOI] 10.1016/j.ajo.2013.04.036. [PMID] 23769193.
2013
Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
JAMA ophthalmology. 131(8):1033-40 [DOI] 10.1001/jamaophthalmol.2013.4154. [PMID] 23807371.
2013
Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema.
JAMA ophthalmology. 131(7):870-9 [DOI] 10.1001/jamaophthalmol.2013.2313. [PMID] 23599174.
2013
Retinal Thickness Normative Data in Wild-Type Mice Using Customized Miniature SD-OCT.
PloS one. 8(6) [DOI] 10.1371/journal.pone.0067265. [PMID] 23826252.
2012
Evaluation of a Novel, Non Contact, Automated Focal Laser with Integrated (NAVILAS) Fluorescein Angiography for Diabetic Macular Edema.
Middle East African journal of ophthalmology. 19(1):158-62 [DOI] 10.4103/0974-9233.92134. [PMID] 22346133.
2012
Lenticular meridional astigmatism secondary to iris mesectodermal leiomyoma.
Journal of cataract and refractive surgery. 38(1):170-3 [DOI] 10.1016/j.jcrs.2011.10.016. [PMID] 22153095.
2012
Meridional lenticular astigmatism associated with bilateral concurrent uveal metastases in renal cell carcinoma.
Clinical ophthalmology (Auckland, N.Z.). 6:1839-41 [DOI] 10.2147/OPTH.S37163. [PMID] 23152663.
2012
Modified protocol for in vivo imaging of wild-type mouse retina with customized miniature spectral domain optical coherence tomography (SD-OCT) device.
Biological procedures online. 14(1) [DOI] 10.1186/1480-9222-14-9. [PMID] 23057840.
2012
Ophthalmology: now and then.
Middle East African journal of ophthalmology. 19(3):271-2 [DOI] 10.4103/0974-9233.97919. [PMID] 22837617.
2012
Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomography.
Investigative ophthalmology & visual science. 53(13):8154-61 [DOI] 10.1167/iovs.12-10290. [PMID] 23132803.
2012
Spectral-domain optical coherence tomography of Roth spots in multiple myeloma.
Eye (London, England). 26(12):1588-9 [DOI] 10.1038/eye.2012.183. [PMID] 22995939.
2012
Webcasts for resident education.
Ophthalmology. 119(1):199-200.e1 [DOI] 10.1016/j.ophtha.2011.08.037. [PMID] 22214944.
2011
Freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples.
Clinical ophthalmology (Auckland, N.Z.). 5:81-5 [DOI] 10.2147/OPTH.S15837. [PMID] 21311660.
2011
Infrared imaging and spectral-domain optical coherence tomography findings correlate with microperimetry in acute macular neuroretinopathy: a case report.
Journal of medical case reports. 5 [DOI] 10.1186/1752-1947-5-536. [PMID] 22040584.
2011
Multiple bilateral ocular metastases from malignant melanoma associated with blue nevi.
European journal of ophthalmology. 21(5):671-3 [DOI] 10.5301/EJO.2011.6375. [PMID] 21360480.
2011
Temporal macular thinning on spectral-domain optical coherence tomography in proliferative sickle cell retinopathy.
Archives of ophthalmology (Chicago, Ill. : 1960). 129(2):247-9 [DOI] 10.1001/archophthalmol.2010.357. [PMID] 21320977.
2010
Comparison of retinal thickness in normal eyes using Stratus and Spectralis optical coherence tomography.
Investigative ophthalmology & visual science. 51(5):2644-7 [DOI] 10.1167/iovs.09-4774. [PMID] 20007831.
2010
Foveal structure defined by spectral domain optical coherence tomography correlates with visual function after macular hole surgery.
European journal of ophthalmology. 20(3):572-7 [PMID] 20099240.
2010
In-vivo high resolution imaging of optic nerve head drusen using spectral-domain Optical Coherence Tomography.
BMC medical imaging. 10 [DOI] 10.1186/1471-2342-10-11. [PMID] 20529261.
2009
Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.
Pharmacogenomics. 10(3):385-97 [DOI] 10.2217/14622416.10.3.385. [PMID] 19290789.
2009
Comparative efficacy of topical tetraVisc versus lidocaine gel in cataract surgery.
BMC ophthalmology. 9 [DOI] 10.1186/1471-2415-9-7. [PMID] 19686592.
2009
Indocyanine green toxicity of the retina after cataract surgery: a case report.
Retinal cases & brief reports. 3(2):115-7 [DOI] 10.1097/ICB.0b013e318162b123. [PMID] 25391050.
2009
Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma.
The British journal of ophthalmology. 93(2):273-4 [DOI] 10.1136/bjo.2008.145714. [PMID] 18617542.
2009
Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).
American journal of ophthalmology. 148(2):266-71 [DOI] 10.1016/j.ajo.2009.03.006. [PMID] 19427616.
2008
Intracameral Avastin Dramatically Resolves Iris Neovascularization and Reverses Neovascular Glaucoma
European Journal of Ophthalmology. 18:255-262
2008
OCT – An Insight into Retinal Disorders.
Middle East African journal of ophthalmology. 15(3):97-8 [DOI] 10.4103/0974-9233.51982. [PMID] 21369463.
2007
Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa.
Retina (Philadelphia, Pa.). 27(8):1112-8 [PMID] 18040255.
2005
Abnormal distribution of red/green cone opsins in a patient with an autosomal dominant cone dystrophy.
Ophthalmic genetics. 26(2):69-76 [PMID] 16020309.
2004
A novel IMPDH1 mutation (Arg231Pro) in a family with a severe form of autosomal dominant retinitis pigmentosa.
Ophthalmology. 111(10):1910-6 [PMID] 15465556.
2004
Dark adaptation of rod photoreceptors in normal subjects, and in patients with Stargardt disease and an ABCA4 mutation.
Investigative ophthalmology & visual science. 45(7):2447-56 [PMID] 15223829.
2003
Variability of full-field electroretinogram responses in subjects without diffuse photoreceptor cell disease.
Ophthalmology. 110(6):1159-63 [PMID] 12799241.
2002
Atypical presentation of pattern dystrophy in two families with peripherin/RDS mutations.
Ophthalmology. 109(6):1110-7 [PMID] 12045052.
2002
Comparison of intraocular light scatter in carriers of choroideremia and X-linked retinitis pigmentosa.
Ophthalmology. 109(1):159-63 [PMID] 11772598.
2001
How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?
Diabetes care. 24(1):45-50 [PMID] 11194239.
1999
Conventional and chained standard gambles in the assessment of coronary heart disease prevention and treatment. Canadian Collaborative Cardiac Assessment Group.
Medical decision making : an international journal of the Society for Medical Decision Making. 19(2):149-56 [PMID] 10231077.
1998
Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis.
Proceedings of the National Academy of Sciences of the United States of America. 95(6):3088-93 [PMID] 9501220.
1995
Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study.
BMJ (Clinical research ed.). 310(6985):975-8 [PMID] 7728035.

Grants

Jun 2024 ACTIVE
A Phase 1 Open-Label, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants with Confirmed PRPF31 Mutation-Associated Retinal Dystrophy
Role: Principal Investigator
Funding: ORA via VISION PHARMA PTY
Oct 2023 ACTIVE
A Phase 1 Open-Label, Single Arm Dose Escalation Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants with Confirmed PRPF31 Mutation-Associated Retinal Dystrophy
Role: Principal Investigator
Funding: ORA via VISION PHARMA PTY
Mar 2023 ACTIVE
A Phase 2 Evaluation of Tonabersat for Diabetic Macular Edema (Protocol AN)
Role: Principal Investigator
Funding: JAEB CTR FOR HLTH RES via NATL INST OF HLTH NEI
Feb 2023 ACTIVE
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated with Rare Disease-Causing Genetic Variants (hereinafter may be referred to as, Uni-Rare, Study, or Protocol)
Role: Principal Investigator
Funding: JAEB CTR FOR HLTH RES via FOU FOR FIGHTING BLINDNESS
Sep 2022 ACTIVE
A Natural History and Outcome Measure Discovery Study of PRPF31 MutationAssociated Retinal Dystrophy
Role: Principal Investigator
Funding: LEXITAS PHARMA SERVICES
Jun 2022 ACTIVE
A Randomized, Controlled, Masked, Multi-center Study Evaluating the Efficacy, Safety, and Tolerability of Two Doses of AGTC-501 Compared to an Untreated Control Group in Male Participants with X-linked Retinitis Pigmentosa
Role: Principal Investigator
Funding: BEACON THERAPEUTICS
Mar 2022 ACTIVE
NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial in patients with Retinitis Pigmentosa
Role: Principal Investigator
Funding: JOHNS HOPKINS UNIVERSITY via NATL INST OF HLTH NEI
Jun 2021 ACTIVE
A Phase 1/2 Open-Label Dose Escalation Study to Evaluate the Safety and Efficacy of AGTC-501 (rAAV2tYF-GRK1-RPGR) and a Phase 2 Randomized, Controlled, Masked, Multi-center Study Comparing Two Doses of AGTC-501 in Male Participants with X-linked Retinitis Pigmentosa
Role: Principal Investigator
Funding: BEACON THERAPEUTICS
May 2021 – Dec 2024
A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening (Protocol AF)
Role: Principal Investigator
Funding: JAEB CTR FOR HLTH RES via NATL INST OF HLTH NEI
Nov 2020 ACTIVE
A Phase 2 Multi-center, Randomized, Double-Masked, Sham-Controlled Study of the Safety and Efficacy of Intravitreal Injections of NGM621 in Subjects with Geographic Atrophy (GA) secondary to age-related macular degeneration (AMD).
Role: Principal Investigator
Funding: PPD INVESTIGATOR SERVICES LLC via NGM BIOPHARMACEUTICALS INC
Apr 2019 – Mar 2021
STUDY OF COMPARATIVE TREATMENTS FOR RETINAL VEIN OCCLUSION 2(SCORE2)
Role: Principal Investigator
Funding: PENNSYLVANIA STATE UNIV via NATL INST OF HLTH NEI
Mar 2016 – Dec 2016
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients with Neovascular Age-related Macular Degeneration 150998-005
Role: Principal Investigator
Funding: ALLERGAN SALES
Aug 2015 – Aug 2018
A PHASE 2 DOUBLE MASKED RANDOMIZED CONTROLLED MULTIPLE DOSE REGIMEN RANGING STUDY OF THE EFFICACY AND SAFETY OF ……..
Role: Principal Investigator
Funding: PAREXEL INTERNATIONAL PTY via REGENERON PHARMACEUTICALS
Sep 2013 – Mar 2019
STUDY OF COMPARATIVE TREATMENTS FOR RETINAL VEIN OCCLUSION 2(SCORE)
Role: Principal Investigator
Funding: PENNSYLVANIA STATE UNIV via NATL INST OF HLTH
Jan 2011 – Dec 2024
Diabetic Retinopathy Clinical Research Network
Role: Principal Investigator
Funding: JAEB CTR FOR HLTH RES via NATL INST OF HLTH NEI

Education

Ophthalmology Residency
2004 · University of Illinois College of Medicine at Chicago
Electrophysiology and Medical Retinal Disease Fellowship
1999 · University of Illinois College of Medicine at Chicago
Neuro-Ophthalmology Fellowship
1994 · University of Illinois College of Medicine at Chicago
Bachelor of Medicine, Bachelor of Surgery
1985 · Rohtak Medical College

Contact Details

Phones:
Business:
(904) 244-9390
Emails:
Senior GME Prog – Opth:
Starleatha D Pollard
View Profile
Addresses:
Business Mailing:
580 WEST 8TH STREET
580 W 8TH ST
DEPT OF OPHTHALMOLOGY
JACKSONVILLE FL 322096533
Business Street:
TOWER II, 3RD FLOOR
580 W 8TH ST
DEPARTMENT OF OPHTHALMOLOGY
JACKSONVILLE FL 322096533